Launchit Ventures partners with metaMe Health to market Regulora, an FDA-cleared Digital Therapeutic for IBS, in Canada

Launchit Ventures

metaMe Health licenses the Regulora digital therapeutic in Canada to Launchit Ventures to expedite the supply of Regulora for Irritable Bowel Syndrome

HAMILTON, ONTARIO, CANADA, September 30, 2022 /EINPresswire.com/ — Launchit Ventures Inc., a HealthTech options supplier and world commercialization companion creating new technology-led business options sooner and with much less danger, and metaMe Health Inc., a Prescription Digital Therapeutics (PDT) firm and developer of Regulora^®, right now introduced a worldwide partnership to deliver Regulora^® to the Canadian market for the therapy of stomach ache due to IBS.

IBS is a power situation that impacts 10-15% of adults in the United States, roughly 25 to 45 million folks.(1) Notably, an estimated 13-20% of the inhabitants (roughly 5 to 7.5 million folks) live with IBS in Canada.2 On common, Canadians with IBS miss an common of 13 days of labor per yr, main to $8 billion in misplaced productiveness.2 Published information estimates the financial burden of IBS is $6.5 billion yearly in Canada.(2)

metaMe Health’s Regulora^® is the primary U.S. FDA-authorized PDT particularly for stomach ache related with IBS in adults. It supplies self-administered Gut-Directed Hypnotherapy (GDH) by way of a handy iOS and Android app that can be utilized at house alongside with different IBS therapies. Until now, the supply of GDH has been restricted, because it required in-person administration by specialised therapists.

Launchit Ventures will work to receive regulatory authorization in Canada and can develop a commercialization technique and execution plan to make Regulora^® out there to sufferers with IBS in Canada markets.

Tim Rudolphi, CEO at metaMe Health, says, “We’re excited to expand the availability of our first Prescription Digital Therapeutic, Regulora^® outside of the U.S. It is great to have a trusted partner like Launchit Ventures to manage the complexities of the Canadian commercialization and regulatory processes required to take Regulora^® to market.”

Jamie Harsevoort, CEO at Launchit Ventures, provides, “We are excited to further enable metaMe Health’s mission to provide an innovative treatment option to patients with abdominal pain due to IBS. With an estimated 5 to 7.5 million IBS patients in Canada, we have a tremendous opportunity to make a difference in patients’ lives by providing a proven therapy that they can access easily at home.”

PDTs ship evidence-based therapeutic interventions by way of high-quality software program packages to forestall, handle, or deal with a medical dysfunction or illness. PDTs incorporate superior expertise, design finest practices, scientific analysis, usability research, and information safety, and are developed below the identical rigorous situations as prescribed drugs – full with scientific trials, regulatory clearance, and availability by way of a doctor’s prescription.

PDTs will proceed to be a key piece of the rising world digital market. In latest years, greater than $12.5 billion has been invested in digital well being start-ups. According to one estimate, the worth of all digital well being start-ups might attain $500 billion by 2025.(3)

About metaMe Health, Inc.

metaMe Health, Inc. is a U.S. firm that develops Prescription Digital Therapeutics (PDTs) for the therapy of frequent power situations. metaMe Health’s preliminary digital options intention to relieve the ache and disruption of on a regular basis life skilled by hundreds of thousands affected by gastrointestinal problems. By permitting sufferers to be prescribed therapy confidentially and to bear therapy privately at house, metaMe Health affords non-drug choices that present reduction in a well-recognized, snug setting. For further info, please go to metamehealth.com or comply with @metaMeHealth on Twitter and metaMe Health on LinkedIn.

About Launchit Ventures, Inc.

Launchit Ventures, Inc. is a HealthTech enterprise studio that provides a brand new mannequin for entrepreneurship, combining firm constructing with enterprise funding, to develop new companies sooner and with much less danger. Launchit Ventures partners with researchers, entrepreneurs, trade veterans, and others who’ve nice concepts however want help and experience to commercialize them. The Launchit Ventures crew and its partners bridge the hole between a founder with an thought and the precise actuality of getting a HealthTech start-up services or products into the market. Learn extra at https://launchitventures.com.

MEDIA CONTACTS

Kelsey BaRoss
RoseComm for metaMe Health, Inc.
[email protected]

Jamie Harsevoort
Launchit Ventures, Inc.
[email protected]

References

(1) IBS Facts and Statistics. Accessed September 19, 2022. Learn extra: https://aboutibs.org/what-is-ibs/facts-about-ibs/.
(2) Gastrointestinal Society and Canadian Society of Intestinal Research. IBS Facts. Accessed September 19, 2022. Learn extra: https://badgut.org/information-centre/a-z-digestive-topics/ibs-awareness/
(3) McCann C. Realizing the promise of prescription digital therapeutics. STAT. Published October 29, 2019. Accessed September 19, 2022. Learn extra: https://www.statnews.com/2019/10/29/prescription-digital-therapeutics-realizing-promise/

Jamie Harsevoort
Launchit Ventures Inc.
e-mail us right here